Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
This report aims to provide a comprehensive presentation of the global market for Drug Modeling Softwares, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Modeling Softwares. This report contains market size and forecasts of Drug Modeling Softwares in global, including the following market information:
Global Drug Modeling Softwares Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drug Modeling Softwares market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Database Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drug Modeling Softwares include JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, Schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes and Acellera, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drug Modeling Softwares companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Modeling Softwares Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drug Modeling Softwares Market Segment Percentages, by Type, 2022 (%)
Database
Software
Others
Global Drug Modeling Softwares Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drug Modeling Softwares Market Segment Percentages, by Application, 2022 (%)
Drug Discovery and Development
Computational Physiological Medicine
Disease Modelling
Medical Imaging
Predictive Analysis of Drug Targets
Simulation Software
Cellular Simulation
Others
Global Drug Modeling Softwares Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drug Modeling Softwares Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Modeling Softwares revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drug Modeling Softwares revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
JSR Corporation(Crown Bioscience)
Chemical Computing Group ULC
Nimbus Therapeutics
Schrodinger, Inc
Genedata AG
Biognos AB
Compugen Ltd
Dassault Systemes
Acellera
Instem(Leadscope)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Modeling Softwares, market overview.
Chapter 2: Global Drug Modeling Softwares market size in revenue.
Chapter 3: Detailed analysis of Drug Modeling Softwares company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Modeling Softwares in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drug Modeling Softwares Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Modeling Softwares Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Modeling Softwares Overall Market Size
2.1 Global Drug Modeling Softwares Market Size: 2022 VS 2029
2.2 Global Drug Modeling Softwares Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Modeling Softwares Players in Global Market
3.2 Top Global Drug Modeling Softwares Companies Ranked by Revenue
3.3 Global Drug Modeling Softwares Revenue by Companies
3.4 Top 3 and Top 5 Drug Modeling Softwares Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drug Modeling Softwares Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Modeling Softwares Players in Global Market
3.6.1 List of Global Tier 1 Drug Modeling Softwares Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Modeling Softwares Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drug Modeling Softwares Market Size Markets, 2022 & 2029
4.1.2 Database
4.1.3 Software
4.1.4 Others
4.2 By Type - Global Drug Modeling Softwares Revenue & Forecasts
4.2.1 By Type - Global Drug Modeling Softwares Revenue, 2018-2023
4.2.2 By Type - Global Drug Modeling Softwares Revenue, 2024-2029
4.2.3 By Type - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drug Modeling Softwares Market Size, 2022 & 2029
5.1.2 Drug Discovery and Development
5.1.3 Computational Physiological Medicine
5.1.4 Disease Modelling
5.1.5 Medical Imaging
5.1.6 Predictive Analysis of Drug Targets
5.1.7 Simulation Software
5.1.8 Cellular Simulation
5.1.9 Others
5.2 By Application - Global Drug Modeling Softwares Revenue & Forecasts
5.2.1 By Application - Global Drug Modeling Softwares Revenue, 2018-2023
5.2.2 By Application - Global Drug Modeling Softwares Revenue, 2024-2029
5.2.3 By Application - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Drug Modeling Softwares Market Size, 2022 & 2029
6.2 By Region - Global Drug Modeling Softwares Revenue & Forecasts
6.2.1 By Region - Global Drug Modeling Softwares Revenue, 2018-2023
6.2.2 By Region - Global Drug Modeling Softwares Revenue, 2024-2029
6.2.3 By Region - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Drug Modeling Softwares Revenue, 2018-2029
6.3.2 US Drug Modeling Softwares Market Size, 2018-2029
6.3.3 Canada Drug Modeling Softwares Market Size, 2018-2029
6.3.4 Mexico Drug Modeling Softwares Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Drug Modeling Softwares Revenue, 2018-2029
6.4.2 Germany Drug Modeling Softwares Market Size, 2018-2029
6.4.3 France Drug Modeling Softwares Market Size, 2018-2029
6.4.4 U.K. Drug Modeling Softwares Market Size, 2018-2029
6.4.5 Italy Drug Modeling Softwares Market Size, 2018-2029
6.4.6 Russia Drug Modeling Softwares Market Size, 2018-2029
6.4.7 Nordic Countries Drug Modeling Softwares Market Size, 2018-2029
6.4.8 Benelux Drug Modeling Softwares Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Drug Modeling Softwares Revenue, 2018-2029
6.5.2 China Drug Modeling Softwares Market Size, 2018-2029
6.5.3 Japan Drug Modeling Softwares Market Size, 2018-2029
6.5.4 South Korea Drug Modeling Softwares Market Size, 2018-2029
6.5.5 Southeast Asia Drug Modeling Softwares Market Size, 2018-2029
6.5.6 India Drug Modeling Softwares Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Drug Modeling Softwares Revenue, 2018-2029
6.6.2 Brazil Drug Modeling Softwares Market Size, 2018-2029
6.6.3 Argentina Drug Modeling Softwares Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drug Modeling Softwares Revenue, 2018-2029
6.7.2 Turkey Drug Modeling Softwares Market Size, 2018-2029
6.7.3 Israel Drug Modeling Softwares Market Size, 2018-2029
6.7.4 Saudi Arabia Drug Modeling Softwares Market Size, 2018-2029
6.7.5 UAE Drug Modeling Softwares Market Size, 2018-2029
7 Drug Modeling Softwares Companies Profiles
7.1 JSR Corporation(Crown Bioscience)
7.1.1 JSR Corporation(Crown Bioscience) Company Summary
7.1.2 JSR Corporation(Crown Bioscience) Business Overview
7.1.3 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Major Product Offerings
7.1.4 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.1.5 JSR Corporation(Crown Bioscience) Key News & Latest Developments
7.2 Chemical Computing Group ULC
7.2.1 Chemical Computing Group ULC Company Summary
7.2.2 Chemical Computing Group ULC Business Overview
7.2.3 Chemical Computing Group ULC Drug Modeling Softwares Major Product Offerings
7.2.4 Chemical Computing Group ULC Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.2.5 Chemical Computing Group ULC Key News & Latest Developments
7.3 Nimbus Therapeutics
7.3.1 Nimbus Therapeutics Company Summary
7.3.2 Nimbus Therapeutics Business Overview
7.3.3 Nimbus Therapeutics Drug Modeling Softwares Major Product Offerings
7.3.4 Nimbus Therapeutics Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.3.5 Nimbus Therapeutics Key News & Latest Developments
7.4 Schrodinger, Inc
7.4.1 Schrodinger, Inc Company Summary
7.4.2 Schrodinger, Inc Business Overview
7.4.3 Schrodinger, Inc Drug Modeling Softwares Major Product Offerings
7.4.4 Schrodinger, Inc Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.4.5 Schrodinger, Inc Key News & Latest Developments
7.5 Genedata AG
7.5.1 Genedata AG Company Summary
7.5.2 Genedata AG Business Overview
7.5.3 Genedata AG Drug Modeling Softwares Major Product Offerings
7.5.4 Genedata AG Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.5.5 Genedata AG Key News & Latest Developments
7.6 Biognos AB
7.6.1 Biognos AB Company Summary
7.6.2 Biognos AB Business Overview
7.6.3 Biognos AB Drug Modeling Softwares Major Product Offerings
7.6.4 Biognos AB Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.6.5 Biognos AB Key News & Latest Developments
7.7 Compugen Ltd
7.7.1 Compugen Ltd Company Summary
7.7.2 Compugen Ltd Business Overview
7.7.3 Compugen Ltd Drug Modeling Softwares Major Product Offerings
7.7.4 Compugen Ltd Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.7.5 Compugen Ltd Key News & Latest Developments
7.8 Dassault Systemes
7.8.1 Dassault Systemes Company Summary
7.8.2 Dassault Systemes Business Overview
7.8.3 Dassault Systemes Drug Modeling Softwares Major Product Offerings
7.8.4 Dassault Systemes Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.8.5 Dassault Systemes Key News & Latest Developments
7.9 Acellera
7.9.1 Acellera Company Summary
7.9.2 Acellera Business Overview
7.9.3 Acellera Drug Modeling Softwares Major Product Offerings
7.9.4 Acellera Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.9.5 Acellera Key News & Latest Developments
7.10 Instem(Leadscope)
7.10.1 Instem(Leadscope) Company Summary
7.10.2 Instem(Leadscope) Business Overview
7.10.3 Instem(Leadscope) Drug Modeling Softwares Major Product Offerings
7.10.4 Instem(Leadscope) Drug Modeling Softwares Revenue in Global Market (2018-2023)
7.10.5 Instem(Leadscope) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drug Modeling Softwares Market Opportunities & Trends in Global Market
Table 2. Drug Modeling Softwares Market Drivers in Global Market
Table 3. Drug Modeling Softwares Market Restraints in Global Market
Table 4. Key Players of Drug Modeling Softwares in Global Market
Table 5. Top Drug Modeling Softwares Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drug Modeling Softwares Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drug Modeling Softwares Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drug Modeling Softwares Product Type
Table 9. List of Global Tier 1 Drug Modeling Softwares Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Modeling Softwares Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drug Modeling Softwares Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Drug Modeling Softwares Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drug Modeling Softwares Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Drug Modeling Softwares Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Drug Modeling Softwares Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drug Modeling Softwares Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Drug Modeling Softwares Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Drug Modeling Softwares Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drug Modeling Softwares Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Drug Modeling Softwares Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drug Modeling Softwares Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Drug Modeling Softwares Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drug Modeling Softwares Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Drug Modeling Softwares Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drug Modeling Softwares Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Drug Modeling Softwares Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drug Modeling Softwares Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Drug Modeling Softwares Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drug Modeling Softwares Revenue, (US$, Mn), 2024-2029
Table 30. JSR Corporation(Crown Bioscience) Company Summary
Table 31. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Product Offerings
Table 32. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 33. JSR Corporation(Crown Bioscience) Key News & Latest Developments
Table 34. Chemical Computing Group ULC Company Summary
Table 35. Chemical Computing Group ULC Drug Modeling Softwares Product Offerings
Table 36. Chemical Computing Group ULC Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 37. Chemical Computing Group ULC Key News & Latest Developments
Table 38. Nimbus Therapeutics Company Summary
Table 39. Nimbus Therapeutics Drug Modeling Softwares Product Offerings
Table 40. Nimbus Therapeutics Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 41. Nimbus Therapeutics Key News & Latest Developments
Table 42. Schrodinger, Inc Company Summary
Table 43. Schrodinger, Inc Drug Modeling Softwares Product Offerings
Table 44. Schrodinger, Inc Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 45. Schrodinger, Inc Key News & Latest Developments
Table 46. Genedata AG Company Summary
Table 47. Genedata AG Drug Modeling Softwares Product Offerings
Table 48. Genedata AG Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 49. Genedata AG Key News & Latest Developments
Table 50. Biognos AB Company Summary
Table 51. Biognos AB Drug Modeling Softwares Product Offerings
Table 52. Biognos AB Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 53. Biognos AB Key News & Latest Developments
Table 54. Compugen Ltd Company Summary
Table 55. Compugen Ltd Drug Modeling Softwares Product Offerings
Table 56. Compugen Ltd Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 57. Compugen Ltd Key News & Latest Developments
Table 58. Dassault Systemes Company Summary
Table 59. Dassault Systemes Drug Modeling Softwares Product Offerings
Table 60. Dassault Systemes Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 61. Dassault Systemes Key News & Latest Developments
Table 62. Acellera Company Summary
Table 63. Acellera Drug Modeling Softwares Product Offerings
Table 64. Acellera Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 65. Acellera Key News & Latest Developments
Table 66. Instem(Leadscope) Company Summary
Table 67. Instem(Leadscope) Drug Modeling Softwares Product Offerings
Table 68. Instem(Leadscope) Drug Modeling Softwares Revenue (US$, Mn) & (2018-2023)
Table 69. Instem(Leadscope) Key News & Latest Developments
List of Figures
Figure 1. Drug Modeling Softwares Segment by Type in 2022
Figure 2. Drug Modeling Softwares Segment by Application in 2022
Figure 3. Global Drug Modeling Softwares Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drug Modeling Softwares Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drug Modeling Softwares Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drug Modeling Softwares Revenue in 2022
Figure 8. By Type - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 9. By Application - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 10. By Type - Global Drug Modeling Softwares Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 12. By Application - Global Drug Modeling Softwares Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 14. By Region - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 15. By Country - North America Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 16. US Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 20. Germany Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 21. France Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 28. China Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 32. India Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 34. Brazil Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Drug Modeling Softwares Revenue Market Share, 2018-2029
Figure 37. Turkey Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Drug Modeling Softwares Revenue, (US$, Mn), 2018-2029
Figure 41. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Chemical Computing Group ULC Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Nimbus Therapeutics Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Schrodinger, Inc Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Genedata AG Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biognos AB Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Compugen Ltd Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Dassault Systemes Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Acellera Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Instem(Leadscope) Drug Modeling Softwares Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
